Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation

Journal of Cellular Physiology

Volumn 216, Issue 3, 2008, Pages 780-789

  Sanders, Andrew J ^a   Parr, Christian ^a   Martin, Tracey A ^a   Lane, Jane ^a   Mason, Malcolm D ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; MATRIPTASE; MATRIPTASE 2; PAXILLIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NUDE MOUSE; PLASMID; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEMBRANE PROTEINS; MICE; NEOPLASM INVASIVENESS; PAXILLIN; PROSTATIC NEOPLASMS; SERINE ENDOPEPTIDASES; UP-REGULATION;

MAMMALIA; MUS MUSCULUS;

EID: 48749092358     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21460     Document Type: Article

References (40)

1. Allione F, Eisinger F, Pare P, Noguchi T, Sobol H, Birnbaum D. 1998. Loss of heterozygosity at loci from chromosome arm 22q in human sporadic breast carcinomas. Int J Cancer 75:181-186.
2. Castells A, Gusella JF, Ramesh V, Rustgi AK. 2000. A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers. Cancer Res 60:2836-2839.
3. Förbs D, Thiel S, Stella MC, Stürzebecher A, Schweinitz A, Steinmetzer T, Stürzebecher J, Uhland K. 2005. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinomas. Int J Oncol 27:1061-1070.
4. Galkin AV, Mullen L, Fox WD, Brown J, Duncan D, Moreno O, Madison EL, Agus DB. 2004. CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts. Prostate 61:228-235.
5. Giancotti FG, Mainiero F. 1994. Integrin-mediated adhesion and signaling in tumorigenesis. Biochim Biophys Acta 1198:47-64.
6. Hartikainen JM, Tuhkanen H, Kataja V, Eskelinen M, Uusitupa M, Kosma V-M, Mannermaa A. 2006. Refinement of the 22q12-q13 breast cancer-associated region: Evidence of TMPRSS6 as a candidate gene in an eastern Finnish population. Clin Cancer Res 12:1454-1462.
7. Hirano A, Emi M, Tsuneizumi M, Utada Y, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G, Haga S, Kajiwara T, Nakamura Y. 2001. Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer. Clin Cancer Res 7:876-882.
8. Hoang CD, D'Cunha J, Kratzke MG, Casmey CE, Frizelle SP, Maddaus MA, Kratzke RA. 2004. Gene expression profiling identifies matriptase overexpression in malignant mesothelioma. Chest 125:1843-1852.
9. Hooper JD, Clements JA, Quigley JP, Antalis TM. 2001. Type II transmembrane serine proteases: Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem 276:857-860.
10. Iida A, Kurose K, Isobe R, Akiyama F, Sakamoto G, Yoshimoto M, Kasumi F, Nakamura Y, Emi M. 1998. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer. Genes Chromosomes Cancer 21:108-112.
11. Jiang WG, Hiscox S, Hallett MB, Horrobin DF, Mansel RE, Puntis MCA. 1995a. Regulation of the expression of E-cadherin on human cancer cells by gamma linolenic acid. Cancer Res 55:5043-5048.
12. Jiang WG, Hiscox S, Hallett MB, Horrobin DF, Scott C, Puntis MCA. 1995b. Inhibition of invasion and motility of human colon cancer cells by gamma linolenic acid. Br J Cancer 71:744-752.
13. Jiang WG, Hiscox SE, Parr C, Martin TA, Matsumoto K, Nakamura T, Mansel RE. 1999. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clin Cancer Res 5:3695-3703.
14. Jiang WG, Davies G, Fodstad O. 2005a. Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-beta connection. Biochem Biophys Res Commun 330:253-262.
15. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K, Mansel RE. 2005b. Targeting matrilysin and its impact on tumour growth in vivo: The potential implications in breast cancer therapy. Clin Cancer Res 11:6012-6019.
16. Jin X, Yagi M, Akiyama N, Hirosaki T, Higashi S, Lin C-Y, Dickson RB, Kitamura H, Miyazaki K. 2006. Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis. Cancer Sci 97:1327-1334.
17. Lang JC, Schuller DE. 2001. Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck. Br J Cancer 84:237-243.
18. Lee SL, Dickson RB, Lin CY. 2000. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem 275:36720-36725.
19. Lee J-W, Song SY, Choi J-J, Lee S-J, Kim B-G, Park C-S, Lee J-H, Lin C-Y, Dickson RB, Bae D-S. 2005. Increased expression of Matriptase is associated with histopathologic grades of cervical neoplasia. Human Pathol 36:626-633.
20. López-Otin C, Matrisian LM. 2007. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 7:800-808.
21. Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA, Catalona WJ, Watson MA, Milbrandt J. 2001. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 61:5692-5696.
22. Martin TA, Parr C, Davies G, Watkins G, Lane J, Matsumoto K, Nakamura T, Mansel RE, Jiang WG. 2003. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis 24:1317-1323.
23. Mori Y, Kono K, Matsumoto Y, Fujii H, Yamane T, Mitsumata M, Chen WT. 2004. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma. Oncology 67:411-419.
24. Netzel-Arnett S, Hooper JD, Szabo R, Madison EL, Quigley JP, Bugge TH, Antalis TM. 2003. Membrane anchored serine proteases: A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev 22:237-258.
25. Oberst MD, Johnson MD, Dickson RB, Lin C-Y, Singh B, Stewart M, Williams A, al-Nafussi A, Smyth HF, Gabra H, Stellar GC. 2002. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: Correlation with clinical outcome and tumour clinicopathological parameters. Clin Cancer Res 8:1101-1107.
26. Parr C. 2006. Hepatocye growth factor activator inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Int J Cancer 119:1176-1183.
27. Parr C, Watkins G, Mansel RE, Jiang WG. 2004. The hepatocyte growth factor regulatory factors in human breast cancer. Clin Cancer Res 10:202-211.
28. Parr C, Sanders AJ, Davies G, Martin T, Lane J, Mason MD, Mansel RE, Jiang WG. 2007. Matriptase-2 inhibits breast growth and invasion and correlates with favorable prognosis for breast cancer patients. Clin Cancer Res 13:3568-3576.
29. Saleem M, Adhami VM, Zhong W, Longley BJ, Lin C-Y, Dickson RB, Reagan-Shaw S, Jarrad DF, Mukhtar H. 2006. A novel biomarker for staging human prostate adenocarcinoma: Overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1. Cancer Epidemiol Biomarkers Prev 15:217-227.
30. Sanders AJ, Parr C, Davies G, Martin TA, Lane J, Mason MD, Jiang WG. 2006. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. J Exp Therap Oncol 6:39-48.
31. Santin AD, Zhan F, Bellone S, Palmieri M, cane S, Bignotti E, Anfossi S, Gokden M, Dunn D, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J, Pecorelli S. 2004. Gene expression profiles in primary ovarian serous papillary tumours and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer 112:14-25.
32. Stephan C, Yousef GM, Scorilas A, Jung K, Jung M, Kristansen G, Hauptmann S, Kishi T, Nakamura T, Loening SA, Diamandis EP. 2004. Hepsin is highly over expressed in and a new candidate for a prognostic indicator of prostate cancer. J Urol 171:187-191.
33. Takeuchi T, Harris JL, Huang W, Yan KW, Coughlin SR, Craik CS. 2000. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 275:26333-26342.
34. Tanimoto H, Yan Y, Clarke J, Korourian S, Shigemasa K, Parmley TH, Parham GP, O'Brien TJ. 1997. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res 57:2884-2887.
35. Underwood LJ, Shigemasa K, Tanimoto H, Beard JB, Schneider EN, Wang Y, Parmley TH, O'Brien TJ. 2000. Ovarian tumour cells express a novel multi-domain cell surface serine protease. Biochim Biophys Acta 1502:337-350.
36. Velasco G, Cal S, Quesada V, Sánchez LM, López-Qtin C. 2002. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem 277:37637-37646.
37. Vogel LK, Sæbø M, Skjelbred CF, Abell K, Pedersen ED, Vogel U, Kure EH. 2006. The ratio of matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals. BMC Cancer 6:176.
38. Wallrapp C, Hähnel S, Müller-Pillasch F, Burghardt B, Iwamura T, Ruthenbürger M, Lerch MM, Adler G, Gress TM. 2000. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res 60:2602-2606.
39. Yano H, Uchida H, Iwasaki T, Mukai M, Akedo H, Nakamura K, Hashimoto S, Sabe H. 2000. Paxillin α and Crk-associated substrate exert opposing effects on cell migration and contact inhibition of growth through tyrosine phosphorylation. Proc Natl Acad Sci 97:9076-9081.
40. Yano H, Mazaki Y, Kurokawa K, Hanks SK, Matsuda M, Sabe H. 2004. Roles played by a subset of integrin signaling molecules in cadherin-based cell-cell adhesion. J Cell Biol 166:283-295.